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Background: Aortic valve calcification (AVC) and mitral annular calcification (MAC) have been reported to associate with coronary artery 
calcification (CAC) and to predict higher cardiovascular mortality. However, the relationship between AVC/MAC and noncalcified coronary 
atherosclerotic lesion (NCAL) is unknown. Recently, our group reported that “vulnerable” NCAL characteristics assessed by multidetector computed 
tomography (MDCT) included lower CT density and higher vascular remodeling index (RI).
Methods: In 260 consecutive patients (mean age 67 years; 65% men) with suspected coronary artery disease, 64-MDCT was performed and analyzed 
for the presence of CAC and NCAL. The presence of AVC and MAC were determined by two experienced readers and their calcification were scored using 
the Agatston method. Coronary arteries were assessed using a 17-segment model for the presence and extent of NCAL. Each NCAL was classified as 
noncalcified plaque (NCP) or mixed plaque (MP). Minimum CT density <39HU and RI >1.05 were defined as vulnerable features of NCAL.
Results: AVC was present in 163 patients (63%) [median score 21, range 0-1553] and MAC was in 39 (15%) [median 0, range 0-9364]. AVC was 
correlated with CAC score (r=0.53, p<0.001). Patients with both AVC and MAC (AVC+MAC) (n=36, 14%) were more likely to have NCAL (89% vs 67%, 
p=0.009) and 2 vulnerable features of NCAL (67% vs 42%, p=0.007) than those without AVC or MAC. AVC+MAC had larger numbers of NCAL burden 
(3.1±2.2 vs 1.8±1.9 segments, p<0.001) and CAC scores (median: 408 vs 45, p <0.001). After adjustment for CAC and traditional cardiovascular 
risk factors, AVC+MAC was still an independent predictor for the presence of NCAL (OR 6.9, 95%CI 1.5-31.9, p=0.014) and 2 vulnerable features 
of NCAL (OR 2.7, 95%CI 1.1-6.8, p=0.035). When stratified by plaque composition, AVC+MAC were associated with MP (OR 4.9, 95%CI 1.3-17.8, 
p=0.016), but not with NCP (p=0.49). Moreover, this OR increased when analyzing for ≥2 segments with MP (OR 5.9, 95%CI 2.2-15.7, p<0.001).
Conclusions: Accumulation of AVC and MAC is highly related to the presence, extent, and vulnerable characteristics of NCAL, indicating a surrogate 
marker for advanced coronary atherosclerosis.
